News in brief

PURE seeks USDA permission to begin in-plant poultry trials


PURE Bioscience has been backed by the US Food and Drug Administration (FDA) to trial higher concentrations of its antimicrobial to reduce Salmonella and Campylobacter.

The creator of the silver dihydrogen citrate (SDC) antimicrobial received a Preliminary Notification (PNC) authorization letter to do the in-plant poultry processing trials.

Technology is based on patented stabilized ionic silver and offers 24-hour residual protection as well as it being possible to formulate with other compounds.

PURE has submitted the PNC to the USDA seeking permission to begin poultry plant trials using up to 200 PPM of PURE Control.

The pending trials (estimated to begin end of Q1 with results before the end of Q2) will evaluate PURE Control applied as a spray to whole chicken carcasses during Online Reprocessing and Offline Reprocessing.

Hank Lambert, CEO, said: “As soon as we complete the regulatory process to gain approvals for use of SDC throughout poultry processing, we are poised to begin commercialization into this important new market.

“We already have strong interest from major poultry processors in our PURE Control solution to help meet stricter USDA standards for Salmonella control, replace current highly toxic interventions and protect their customers and brand.

“Simultaneously, we have already begun commercializing PURE Control in the +$300m US fresh produce processing aid market - where we also anticipate generating significant market share - with first orders expected this calendar quarter.”

Related News

Picture: PURE Bioscience

PURE pursues USDA backing after FDA approval

USDA approval for PURE Control in OLR is expected towards Q3 2016. © iStock /  Magone

USDA backs certain uses for PURE Control antimicrobial

PURE Bioscience products contain Silver Dihydrogen Citrate

2017 will be ‘breakout’ year for SDC-based tech adoption – PURE Bioscience

PURE Bioscience also expects to withdraw its FCN for the use of SDC on produce

PURE Bioscience ‘deeply disappointed’ after FCN withdrawal

Poultry plant trial for SDC-based PURE Control antimicrobial

PURE to start poultry processing trial for antimicrobial

PURE Bioscience has a range of products already on the market

PURE Bioscience to resubmit FCN after FDA talks

Related Products

See more related products

Submit a comment

Your comment has been saved

Post a comment

Please note that any information that you supply is protected by our Privacy and Cookie Policy. Access to all documents and request for further information are available to all users at no costs, In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information maybe shared with the owners of that document or information.